Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Azitra, Inc.AZTR · Entity 7959 | Chief Financial Officer | April 20, 2026 | April 22, 2026 |
| VivoSim Labs, INC.ONVO · Entity 8386 | See Remarks | December 30, 2024 | January 08, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Azitra, Inc.
Report date April 20, 2026 · Filed April 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right To Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.21 · Expires 2036-04-20 | Direct | 35,524 |
Reported balance
After 2026-04-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-20 · Grant · Acquired 35,524 · Balance 35,524 F1: 1/3rd of the total number of shares of the Company's common stock subject to the option shall vest on the one year anniversary of the date of issuance, the Vesting Commencement Date, and 1/36th of the total number of shares of the Company's common stock subject to the option will vest each calendar month thereafter for the next two years, on the same day of the month as the Vesting Commencement Date |
Filing footnotes · ownership attribution and instrument terms
F1: 1/3rd of the total number of shares of the Company's common stock subject to the option shall vest on the one year anniversary of the date of issuance, the Vesting Commencement Date, and 1/36th of the total number of shares of the Company's common stock subject to the option will vest each calendar month thereafter for the next two years, on the same day of the month as the Vesting Commencement Date
VivoSim Labs, INC.
Report date December 30, 2024 · Filed January 08, 2025
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 20, 2026 Filed Apr 22, 2026 21:30 UTC | Azitra, Inc. AZTR · Entity 7959 | GrantStock Options (Right To Buy) · Derivative | 35,524 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001493152-26-018597 · ownership.xml · derivative · entry 1 Staskey Norm · CIK 0001971477 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,524 Underlying: Common Stock · 35,524 shares Expires 2036-04-20 F1 · derivative.exercise_date: 1/3rd of the total number of shares of the Company's common stock subject to the option shall vest on the one year anniversary of the date of issuance, the Vesting Commencement Date, and 1/36th of the total number of shares of the Company's common stock subject to the option will vest each calendar month thereafter for the next two years, on the same day of the month as the Vesting Commencement Date Read SEC document |
| December 19, 2025 Filed Dec 22, 2025 22:28 UTC | Azitra, Inc. AZTR · Entity 7959 | GrantStock Options (Right To Buy) · Derivative | 15,015 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001493152-25-028848 · ownership.xml · derivative · entry 1 Staskey Norm · CIK 0001971477 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,015 Underlying: Common Stock · 15,015 shares Expires 2035-12-19 F1 · derivative.exercise_date: 25% of the shares of the Company's Common Stock subject to the Option shall vest on the date of issuance, the Vesting Commencement Date, and the remaining balance shall vest in equal monthly installments over the next 36 months of continuous service thereafter. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 01:51 UTC | Azitra, Inc. AZTR · Entity 7959 | PurchaseCommon Stock | 47,600 | $0.21 | $10,034.08 |
DisclosureSEC source: 0001493152-24-012606 · ownership.xml · nonDerivative · entry 1 Staskey Norm · CIK 0001971477 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,100 F1 · price: The reported shares were purchased in the open market in multiple transactions at prices ranging from $0.20 to $0.2168 . The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Azitra, Inc., any stockholder of Azitra, Inc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 01:39 UTC | Azitra, Inc. AZTR · Entity 7959 | PurchaseCommon Stock | 3,300 | $0.30 | $990.00 |
DisclosureSEC source: 0001493152-24-006914 · ownership.xml · nonDerivative · entry 1 Staskey Norm · CIK 0001971477 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,500 Read SEC document |
| September 08, 2023 Filed Oct 3, 2023 20:05 UTC | Azitra, Inc. AZTR · Entity 7959 | GrantStock Options (Right To Buy) · Derivative | 10,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001493152-23-035230 · ownership.xml · derivative · entry 1 Staskey Norm · CIK 0001971477 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-09-08 F1 · derivative.exercise_date: 25% of the shares of the Company's Common Stock subject to the Option shall vest after 12 months of continuous service measured from 09/08/2023, the Vesting Commencement Date, and the remaining balance shall vest in equal monthly installments over the next 36 months of continuous service thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.